Indoco Remedies · NSE: INDOCO · BSE: 532612
Q2 FY24 results · Jul–Sep 2023
Indoco Remedies reported revenue from operations of ₹481.73 crore (up 11.2% from Q2 FY23) and net profit of ₹35.24 crore (down 29.1% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 481.73 | 433.04 | +11.2% | 426.50 | +12.9% |
| Other income | 4.43 | 0.35 | 13x | 0.41 | +980.5% |
| Total income | 486.16 | 433.39 | +12.2% | 426.91 | +13.9% |
| Profit before tax | 46.28 | 67.30 | −31.2% | 33.91 | +36.5% |
| Net profit for the period | 35.24 | 49.73 | −29.1% | 24.18 | +45.7% |
| Attributable to shareholders of the company | 35.08 | 49.73 | −29.5% | 24.39 | +43.8% |
| EPS, basic (₹) | 3.82 | 5.40 | −29.3% | 2.62 | +45.8% |
| Net margin (%) | 7.3 | 11.5 | 5.7 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 473.39 | 432.69 | +9.4% | 422.88 | +11.9% |
| Other income | 1.12 | 0.34 | +229.4% | 0.41 | +173.2% |
| Total income | 474.51 | 433.03 | +9.6% | 423.29 | +12.1% |
| Profit before tax | 44.03 | 67.20 | −34.5% | 35.67 | +23.4% |
| Net profit for the period | 33.14 | 49.64 | −33.2% | 25.94 | +27.8% |
| EPS, basic (₹) | 3.60 | 5.39 | −33.2% | 2.81 | +28.1% |
| Net margin (%) | 7.0 | 11.5 | 6.1 |
Consolidated
- Filed with BSE
- 21 Oct 2023, 13:44 IST
- Board meeting
- 19 Oct 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 21 Oct 2023, 13:44 IST
- Board meeting
- 19 Oct 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE